Related references
Note: Only part of the references are listed.Immunology and immunotherapy approaches for prostate cancer
E. Elkord
PROSTATE CANCER AND PROSTATIC DISEASES (2007)
Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach
Matthew N. Bainbridge et al.
BMC GENOMICS (2006)
Clinical trial results of a HER2/neu (E75) vaccine to prevent recurrence in high-risk breast cancer patients
GE Peoples et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen
CG Drake et al.
CANCER CELL (2005)
Adenovirus transduction and culture conditions affect the immunogenicity of murine dendritic cells
V Salucci et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2005)
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
J Lapointe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Identification of human tumor antigens and its implications for diagnosis and treatment of cancer
Y Kawakami et al.
CANCER SCIENCE (2004)
Potent influence of bovine serum proteins in experimental dendritic cell-based vaccination Protocols
HE Toldbod et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2003)
Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction
JC Schmollinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Genetic portrait of malignant granular cell odontogenic tumour
F Carinci et al.
ORAL ONCOLOGY (2003)
CTLA-4: new insights into its biological function and use in tumor immunotherapy
JG Egen et al.
NATURE IMMUNOLOGY (2002)
Generation of high quantities of viral and tumor-specific human CD4+and CD8+T-cell clones using peptide pulsed mature dendritic cells
JF Fonteneau et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Expression, specificity and immunotherapy potential of prostate-associated genes in murine cell lines
ME Grossmann et al.
WORLD JOURNAL OF UROLOGY (2001)
Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: Comparison of prophylaxis and therapy
A van Elsas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.
SK Nair et al.
NATURE MEDICINE (2000)
Share Paper
